SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 129.14 |
Enterprise Value ($M) | 109.67 |
Book Value ($M) | 58.92 |
Book Value / Share | 0.26 |
Price / Book | 2.19 |
NCAV ($M) | -39.20 |
NCAV / Share | -0.17 |
Price / NCAV | -3.29 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.81 |
Return on Assets (ROA) | -0.73 |
Return on Equity (ROE) | -1.16 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.75 |
Current Ratio | 0.75 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 68.26 |
Assets | 166.39 |
Liabilities | 107.46 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 28.70 |
Operating Income | -66.29 |
Net Income | -66.95 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -44.76 |
Cash from Investing | -21.32 |
Cash from Financing | 56.56 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Sio Capital Management, LLC | 5.06 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
750,989 | 2,194,780 | 34.22 | |
531,346 | 1,908,193 | 27.85 | |
357,484 | 883,424 | 40.47 | |
524,396 | 1,287,917 | 40.72 | |
392,914 | 1,255,267 | 31.30 | |
(click for more detail) |
Similar Companies | |
---|---|
VSTM – Verastem, Inc. | VTGN – Vistagen Therapeutics, Inc. |
VTVT – vTv Therapeutics Inc. | VYNE – VYNE Therapeutics Inc. |
WHWK – Whitehawk Therapeutics, Inc. |